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Stem and progenitor cells maintain a robust DNA replication
program during the tissue expansion phase of embryogenesis.
The unique mechanism that protects them from the increased risk
of replication-induced DNA damage, and hence permits self-renewal,
remains unclear. To determine whether the genome integrity of
stem/progenitor cells is safeguarded by mechanisms involving
molecules beyond the core DNA repair machinery, we created
a nucleostemin (a stem and cancer cell-enriched protein) condi-
tional-null allele and showed that neural-speciﬁc knockout of
nucleostemin predisposes embryos to spontaneous DNA damage
that leads to severe brain defects in vivo. In cultured neural stem
cells, depletion of nucleostemin triggers replication-dependent DNA
damage and perturbs self-renewal, whereas overexpression of
nucleostemin shows a protective effect against hydroxyurea-
induced DNA damage. Mechanistic studies performed in mouse em-
bryonic ﬁbroblast cells showed that loss of nucleostemin triggers
DNA damage and growth arrest independently of the p53 status or
rRNA synthesis. Instead, nucleostemin is directly recruited to DNA
damage sites and regulates the recruitment of the core repair protein,
RAD51, to hydroxyurea-induced foci. This work establishes the pri-
mary function of nucleostemin inmaintaining the genomic stability of
actively dividing stem/progenitor cells by promoting the recruitment
of RAD51 to stalled replication-induced DNA damage foci.
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Stem and progenitor cells play critical roles in embryonic or-ganogenesis, adult tissue regeneration, and tumor develop-
ment. To maintain self-renewing proliferation, they must be
protected from replication-induced DNA damage that limits the
proliferative lifespan of most dividing cells. Replication-induced
DNA damage may occur spontaneously as a result of stalled and
collapsed replication forks, caused by the slowing of the DNA
replication machinery over replication “trouble” zones or pre-
viously unrepaired damage sites (1–3). Alternatively, replication
stalling can be triggered by drugs that deplete the endogenous
nucleotide pool (e.g., hydroxyurea) or inhibit the activity of DNA
replication (e.g., camptothecin). Prolonged replication stalling
will lead to the collapse of replication machinery and double-
strand DNA breaks (DSBs), causing cell cycle arrest and genomic
instability (4, 5). To date, it remains unclear how stem and pro-
genitor cells survive the increased risk of replication-induced DNA
damage during this hyperactive mitotic window of embryogenesis.
Nucleostemin (NS) is a stem cell-enriched nucleolar protein
(6). Its biological signiﬁcance has been illustrated by the early
embryonic lethal phenotype of NS germ-line knockout mice (7),
which ineluctably hinders further analyses of its in vivo function
beyond the blastula stage. To date, the mechanism of NS action
in vivo remains unclear. Although some suggested a connection
to the p53 pathway (6, 8–10), others have shown that NS is
functionally indispensable even in p53-null cells (11, 12). We
recently discovered a function of NS in preventing DNA damage
on interstitial and telomeric chromosomes, which, by far, best
recapitulates its obligatory role in biology (13). Although the
telomere-protecting function of NS is mediated by telomeric
repeat binding factor 1 (TRF1) SUMOylation and promyelo-
cytic leukemia protein isoform IV (PML-IV) recruitment (13),
the role of NS in protecting nontelomeric chromosomes is yet
unknown. We hypothesize that NS may formulate a unique
mechanism that protects stem/progenitor cells from spontaneous
DNA damage as a result of DNA replication. To investigate this
idea, we created the NS-ﬂox (NSf) allele and two NS conditional-
knockout (NScko) mouse models. Analyses of these mouse
models revealed that neural-speciﬁc deletion of NS increases the
frequency of spontaneous DNA damage and eliminates neural
stem cells (NSCs) in the developing neuroepithelium. DNA damage
triggered by NS deletion occurs in a replication-dependent manner
and independently of the p53 status or ribosomal RNA (rRNA)
synthesis. More importantly, NS is capable of being recruited to
DNA damage sites and is required for the efﬁcient recruitment
of RAD51 to stalled replication-induced damage foci. This
work signiﬁes a primary role of NS in maintaining the genomic
stability of stem and progenitor cells.
Results
Creation of a NS Conditional-Knockout Allele. The gene-targeting
strategy was used to generate ES cells with a NSﬂoxneo (NSfn)
allele, which contains a loxP site linked to an frt-ﬂanked phos-
phoglycerate kinase-neomycin (pgk-neo) cassette at 820 bp up-
stream of the ﬁrst exon and a second loxP site in the second
intron (Fig. 1A and Fig. S1A). After germ-line transmission, the
pgk-neo cassette was deleted from the NSfn allele to generate the
NSﬂox (NSf) allele (Fig. S1 B–D). NSf/f homozygotes manifest
normal developmental, growth, and reproductive activities, and
homozygous deletion of the ﬂoxed sequence (NSnull) results in
early embryonic lethality at embryonic day (E) 3.5 (Fig. S1E).
These ﬁndings conﬁrm that the NSf allele is a bona ﬁde conditional-
null allele.
Neural-Speciﬁc Deletion of NS Triggers DNA Damage and Decreases
NSCs in Vivo. To study the NS function in the developing brain,
a nestin promoter-driven Cre (Crenestin) (14) was used to delete
NS in the neuroepithelial stem/progenitor cells (neNScko).
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Homozygous neNScko mice die immediately after birth due to
respiratory failure. Western blots showed that Crenestin-driven
NS deletion reduces NS proteins in the developing forebrain
most signiﬁcantly at E12.5 and older, followed by the decrease of
nestin and proliferative cell nuclear antigen (PCNA) proteins in
E14.5 and older embryos (Fig. 1B). The delayed onset of PCNA
down-regulation compared with that of NS suggests a delayed
cell cycle exit following the loss of NS. To investigate the neural
defects of neNScko mice, embryos were collected at consecutive
developmental stages. Histological analyses showed that the
neuroepithelial morphology of neNScko embryos appears the
same as that of NSf/f embryos at E10.5 (Fig. S2A) but begins to
show reduced cellularity throughout the neural axis at E12.5
(Fig. 1C). At E14.5 and E16.5, neNScko embryos show major
defects in the telencephalic cortex, ganglionic eminence, cere-
bellar primordium, midbrain tectum, smaller diencephalon, mid-
brain and hindbrain tegmentum, and spinal cord compared with
their NSf/f littermates (Fig. 1 D and E). Associated with those
defects is a decrease of NSCs in neNScko neuroepithelium at E12.5
(Fig. 1F). We also noticed that E12.5 neNScko embryos show a
signiﬁcant increase of γ-H2AX proteins and γ-H2AX+ cells in
their neuroepithelium (Fig. 1 B and G and Fig. S2B).
NS Protects NSCs from DNA Damage and Maintains Their Self-
Renewal. NSCs were isolated from the E12.5 forebrain cortex
and grown as neurospheres in suspension culture. Confocal
analyses showed that most nestin+, NS+, and BrdU-labeled cells
are found in the peripheral region of the sphere (Fig. 2A). The
siRNA-based knockdown approach allows a 60% reduction of
NS proteins in neurospheres (Fig. 2B1) and produces a striking
increase of γ-H2AX+ cells spontaneously (P < 0.0001, Fig. 2 B2
and B3). This NS RNAi (siNS)-mediated knockdown (NSKD)
efﬁciency for the whole neurosphere is moderate compared with
what we’ve seen in monolayer cultures (80–90%), which may be
due to the three-dimensional structure of neurospheres. DNA
replication is one major source of spontaneous DNA damage
that occurs in the S-phase cells. We noted that NSKD causes more
DNA damage on S-phase (BrdU+) neurosphere cells compared
with non–S-phase (BrdU−) cells (Fig. 2C). Conversely, overex-
pression of NS can reduce the amount of DNA damage caused
by hydroxyurea (HU) in NSCs (Fig. 2D). Along with its DNA
damage effect, NS depletion also impairs the self-renewal of
NSCs, as indicated by the decreased tertiary sphere formation
from secondary neurosphere cells (358.3 versus 61.3 spheres per
105 plated cells) (Fig. 2E). These results demonstrate that NS
plays an important role in maintaining the self-renewal of NSCs
by protecting them from replication-dependent DNA damage.
NSKO-Induced DNA Damage Does Not Depend on p53 or Affect rRNA
Synthesis. To deﬁne the role of p53 in the NSKO event, a TAM-
inducible NScko mouse model (inNScko) was created by intro-
ducing the CreER transgene (15) into NSf/f mice, followed by
breeding of inNScko and NSf/f mice into the p53-null background
(16). Mouse embryonic ﬁbroblast (MEF) cells were prepared
from E13.5 embryos. Western blots showed that TAM treatment
(0.1 μM) decreases the NS protein level by 70% in p53-wild type
inNScko cells (lanes 3 and 4) and by >90% in p53-null inNScko
cells (lanes 7 and 8), but has no effect on NSf/f cells (Fig. 3A). Cell
growth studies showed that loss of NS impairs the long-term
proliferative potential of MEF cells, as shown by the reduced
population doubling level (PDL) and early growth plateau (Fig.
3B), and that p53 deletion allows NS wild-type MEF cells to
escape senescence but signiﬁcantly shortens the lifespan of
NSKO cells (Fig. 3C). DNA damage analyses showed that NS
deletion increases the percentage of γ-H2AX+ MEF cells re-
gardless of their p53 status (P < 0.0001) (Fig. 3D), indicating that
the p53 activity is not required for the NSKO-induced DNA
damage. To verify that the DNA damage phenotype of NSKO
cells is caused speciﬁcally by the loss of NS, we restored the NS
expression by introducing a recombinant NS-GFP into NSKO
MEF cells, and conﬁrmed that the expression of NS-GFP can
reduce the γ-H2AX+ percentage of NSKO MEF cells (3.1%)
compared with the expression of GFP (19.6%, P < 0.0001) (Fig.
3E). In addition, the NSdB mutant of NS, which lacks the
Fig. 1. Neural-speciﬁc deletion of nucleostemin
(NS) induces DNA damage, decreases embryonic
neural stem cells (NSCs), and causes severe brain
defects in vivo. (A) Diagrams of the NS-ﬂox (NSf)
and null (NSnull) alleles. Black arrowheads, loxP; gray
arrowheads, frt. (B) Crenestin-driven NS deletion
(neNScko) decreases its protein in the developing
forebrain from embryonic day 12.5 (E12.5). The
levels of nestin and PCNA proteins are reduced
from E14.5. An increase of γ-H2AX proteins is noted
in the neNScko forebrain at E12.5. Tuj1, neuron-
speciﬁc β-tubulin; GFAP, glial ﬁbrillary acid protein.
(C) Compared with control NSf/f embryos, neNScko
embryos begin to show a decreased cellularity in
the telencephalic (T), diencephalic (D), mesencephalic
(M), and rhombencephalic (R) neuroepithelium at
E12.5. Squares indicate regions shown in G and Fig.
S2B. At E14.5 (D) and E16.5 (E), neNScko embryos
exhibit severe brain defects throughout the neural
axis. Ce, cerebellar primordium. (F) At E12.5, the
forebrains of neNScko embryos contain much less
sphere-forming NSCs than that of NSf/f embryos. (G)
A notable phenotype of NS deletion is the increase
of γ-H2AX+ cells in the ventricular zone of the E12.5
neuroepithelium. The region shown here is close
to the midbrain roof. (Scale bars: 500 μm in C, 1 mm
in D and E, and 100 μm in F and G.) Bar graphs,
mean ± SEM; *P < 0.01; **P < 0.001; ***P < 0.0001.
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nucleolar localization signal and hence is distributed in the nu-
cleoplasm, retains the same ability as wild-type NS to rescue the
DNA damage effect of NSKO, suggesting that nucleolar locali-
zation is not a prerequisite for the genome-protecting function
of NS. To address the issue of whether NSKO may cause DNA
damage secondarily to the perturbation of ribosomal synthesis,
we measured the NSKO effect on the levels of pre-rRNA tran-
scripts containing the processing site-1 (PS-1), PS-2, PS-3, or 18S
rRNA sequences by real-time RT-PCR (Fig. 3F, Left). The dif-
ferent PS-containing products represent precursor species that
exist before the splicing events occurring at different stages of
pre-rRNA processing. Although NSKO reduces NS transcripts
Fig. 2. Loss of NS induces DNA damage and per-
turbs self-renewal in NSCs. (A) NSCs were isolated
from the E12.5 cortex of NSf/f embryos and cultured
as neurospheres. Dividing neuroepithelial precursors
(BrdU+ [green] and nestin+ [blue]) are found in the
peripheral zone of the sphere and coincide mostly
with the NS signal (red). (A1) shows a stacked image
(Left) and a single slice through the center (Right).
(A2) shows an enlarged view of a single slice close to
the surface. (B1) RNAi-based NS knockdown (siNS)
gives a 60% knockdown efﬁciency in the whole
neurosphere. (B2 and B3) Loss of NS signiﬁcantly
increases the number of γ-H2AX+ cells in neuro-
spheres. (C) The S-phase (BrdU+) cells are much more
susceptible to the DNA damage effect of NSKD than
the non–S-phase (BrdU−) cells. (D) NS overexpression
protects neurosphere cells from hydroxyurea (HU)-
induced DNA damage (γ-H2AX+). (E) NSKD by siNS
signiﬁcantly diminishes the ability of secondary neu-
rosphere cells to form tertiary neurospheres. y axis
indicates the number of tertiary neurospheres
formed for every 1,000 secondary neurosphere cells
plated. (Scale bars: 100 μm in A1 and B–E, 25 μm in
A2.) Bar graphs (see description in Fig. 1).
Fig. 3. NSKO-induced DNA damage does not de-
pend on p53 or rRNA synthesis. (A) A tamoxifen
(TAM)-inducible NS conditional-KO model (inNScko)
was generated. TAM treatment (0.1 μM, 4 d) reduces
NS proteins in p53 wild-type and null inNScko MEF
cells. (B) The population doubling level (PDL) of p53-
wildtype MEF cells is decreased by NSKO. (C) Deletion
of p53 increases the PDL of NS wild-type cells (red,
green, blue) and decreases the PDL of NS-null cells
(black) compared with their respective p53wt controls
(gray). (D) TAM-induced NSKO increases the per-
centage of γ-H2AX+ cells in p53 wild-type and null
MEF cells. (E) Transfection of NS-GFP or NSdB-GFP
reduces the γ-H2AX+ percentage in transfected NSKO
MEF cells compared with GFP-transfected NSKO cells.
(Scale bars, 50 μm.) (F Left) Diagram of the pre-rRNA–
processing step and the primer-targeting sites for
the processing site-1 (PS-1), PS-2, PS-3, and the 18S-
containing transcripts (PS-4). (Right) Quantitative
RT-PCR shows that NSKO reduces the NS transcript
but has no effect on the PS-1, PS-2, and PS-3 events.
Neither does it reduce the total amount of pre-
rRNAs and rRNAs (PS-4). The transcript levels are
quantiﬁed by referencing to high mobility group
protein 14 (HMG-14) and compared with the DMSO-
treated NSf/f samples.
Meng et al. PNAS | July 9, 2013 | vol. 110 | no. 28 | 11417
CE
LL
BI
O
LO
G
Y
and elicits a clear DNA damage response, it has no effect on
the splicing events occurring on the 47S pre-rRNA or at the
junctions of 5′ETS-18S (PS-2) or 18S-ITS1 (PS-3). Neither does
it reduce the total amount of pre-rRNAs and rRNAs, as measured
by the PS-4 qRT-PCR (Fig. 3F, Right). These results prove that the
DNA damage effect of NSKO does not depend on the p53 activity
and nor is it caused by the impairment of rRNA synthesis.
Loss of NS Triggers Replication-Induced DNA Damage. We noticed
that NSKD in MEF cells increases not only the percentage of
γ-H2AX+ cells (from 4.1% to 16.6%, P < 0.0001) but also the
percentages of ataxia telangiectasia and Rad3-related (ATR)+
(from 3% to 21%, P < 0.01) and replication protein A-32
(RPA32)+ cells (from 4% to 23%, P < 0.01) (Fig. 4 A and B).
Most of the ATR+ and RPA32+ foci colocalize with each other.
NSKD also increases the number of DNA damage foci labeled
by γ-H2AX, ATR, or breast cancer type 1 (BRCA1) in dysplastic
oral keratinocytes cells (Fig. S3). We noted that 55.7% of the
NS-depleted MEF cells in S-phase show γ-H2AX+ signals and
only 7.8% of the non–S-phase cells are γ-H2AX+. This DNA
damage proﬁle resembles that of HU treatment (Fig. 4C). To
bolster the link between NSKD-triggered damage and DNA
replication, we performed propidium iodide-γ-H2AX–doubled
labeled ﬂow cytometry on control-KD (siScr) and NSKD (siNS)
MEF cells. The ﬂow cytometry results conﬁrm that NSKD sig-
niﬁcantly increases the percentage of γ-H2AX+ cells compared
with the control-KD samples (Fig. S4A). Cell cycle analyses on
the γ-H2AX–labeled (Fig. S4B1) versus γ-H2AX–nonlabeled
subpopulation (Fig. S4B2) of NSKD cells also prove that a sig-
niﬁcant portion of NSKD-induced DNA damage occurs in the
S-phase cells. By pooling the S-phase cells from both the γ-H2AX–
labeled and nonlabeled populations, we ﬁnd that 80.1% of the
S-phase cells show γ-H2AX+ signals, whereas only 25.5% of the
non–S-phase cells show γ-H2AX+ signals (P < 0.01, Fig. S4C).
To further support the idea, we demonstrated that the DNA
damage effect of NSKD is greatly reduced in slowly dividing
MEF cells grown under the serum deprivation condition (1.9%)
compared with those grown in 10% (vol/vol) serum (16.6%), and
shows no difference from the scrambled RNAi (siScr)-treated
cells grown in low-serum medium (1.3%) (Fig. 4D, Left). This
lack of siNS effect in slowly dividing MEF cells is not caused
by a decreased NSKD efﬁciency (Fig. 4D, Right). To determine
Fig. 4. NS depletion triggers replication-induced DNA damage. (A) The siNS treatment produces a 90% protein knockdown efﬁciency in MEF cells and
a signiﬁcant increase of γ-H2AX+ cells. (B) NSKD also increases the percentages of ATR+ and RPA32+ cells. Most of the ATR+ and RPA32+ foci are colocalized.
(C) S-phase (BrdU+) cells are much more susceptible to the DNA damage effect of NSKD than non–S-phase cells, which resembles the DNA damage proﬁle of
HU treatment. (D) The siNS-induced DNA damage is signiﬁcantly diminished in MEF cells grown in low serum-containing medium. The siNS-mediated KD
efﬁciency for the low-serum culture condition is the same as that for the normal-serum culture condition. (E) DR-GFP U2OS cells (upper panel) were
transfected with the empty vector or HA-tagged NS plasmid. After introducing DSB at the I-SceI site, ChIP analyses were performed by precipitation with anti-
HA antibody and PCR ampliﬁcation with DSB-speciﬁc or control primers. The DSB-ChIP assay demonstrates that NS is physically associated with DSB sites. (F)
HU treatment (in U2OS cells) induces the foci formation of endogenous NS (detected by Ab2438) in the nucleoplasm without apparently diminishing its
nucleolar signals. The percentages of cells showing ≥ 5 foci of colocalized NS (green) and γ-H2AX (red) signals are quantiﬁed by confocal analyses (gray bars),
and independently conﬁrmed by using the HA-tagged NS recombinant protein (black bars). (Scale bars: 50 μm in A–C; 5 μm in F.)
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whether NS is directly involved in the response and/or repair of
DNA damage, we performed the DSB-chromatin coimmuno-
precipitation (ChIP) assay in DR-GFP-U2OS cells (17). The DR-
GFP-U2OS cells were stably transfected with the SceGFP trans-
gene, which contains an internal I-SceI site (depicted in Fig. 4E,
Upper). DSBs were introduced speciﬁcally at the I-SceI site by
the expression of I-SceI enzyme. Primers were designed to detect
the DNA sequence localized at 500 bp upstream to the I-SceI
site. The DSB-ChIP results showed that immunoprecipitating
HA-tagged NS can physically pull down the I-SceI–cut DSB site
on the SceGFP locus at the 24-h and 48-h time points following
the expression of I-SceI. Compared with the wild-type NS, the
non–GTP-binding mutant of NS (G256V) shows a faster clear-
ance from the I-SceI–cut site (Fig. 4E, Lower). In consistence,
confocal studies demonstrated that, following the HU treatment,
the endogenous NS protein in 25% of the cells forms discrete
foci in the nucleoplasm without losing its nucleolar signals, and
44% of the cells overexpressing HA-tagged NS shows foci for-
mation by the recombinant protein (Fig. 4F). Some NS+ and NS-
HA+ foci are colocalized with the γ-H2AX+ signals. These data
indicate that NS may play a direct and primary role in reducing
the amount of spontaneous DNA damage associated with the
DNA replication process.
NS Depletion Perturbs the Recruitment of RAD51 to Stalled
Replication-Induced Damage Foci. Increased DNA damage by NS
depletion may be caused by an increased source of DNA dam-
age, induced secondarily by stress, or by impaired DNA damage
repair. In the latter case, one should be able to identify the point
of perturbation in the DNA repair axis. As homologous recom-
bination (HR) is the main mechanism responsible for repairing
replication-induced DNA damage (18) and knockout of the core
HR protein, RAD51, shows the same early embryonic lethal
phenotype as does NSKO (19), we hypothesize that the re-
cruitment of RAD51 to DNA damage sites may be a target of
NS regulation. To date, only a handful of proteins (i.e., BRCA2,
RPA70, Bloom’s syndrome protein, and RAD52) are implicated
in the loading of RAD51 to DNA damage sites. To look for the
potential targets of NS, we tested the ability of BRCA2, RPA70
and RAD51 in rescuing the DNA damage phenotype of NSKO
MEF cells, and found that only RAD51, but not BRCA2 or
RPA70, is capable of doing so (Fig. 5A), suggesting that RAD51
may be a direct target of NS. Indeed, coimmunoprecipitation
assays conﬁrm that the endogenous NS and RAD51 proteins can
interact with each other in vivo (Fig. 5B). To determine the role
of NS in regulating the recruitment of RAD51, control-KD and
NSKD MEF cells were treated with HU (2 mM) for 24 h and
assayed for their RAD51 recruitment efﬁciency. The results
showed that, in control-KD MEF cells, HU treatment signiﬁ-
cantly increases the percentages of γ-H2AX+ (28.0%, P <
0.0001, Fig. 5C) and RAD51+ cells (30.4%, P < 0.0001, Fig. 5D)
over the non–HU-treated MEF cells (4.1% for γ-H2AX+ cells
and 3.8% for RAD51+ cells). In contrast, HU treatment of
NSKD MEF cells increases γ-H2AX+ cells signiﬁcantly (33.6%,
Fig. 5C), but its effect on triggering RAD51+ foci is greatly re-
duced (12.4%) compared with its effect in control-KD cells
(30.4%, P < 0.0001) (Fig. 5D). Finally, we performed DSB-ChIP
experiments to conﬁrm that NS is required for the physical re-
cruitment of RAD51 to DSB sites (Fig. 5E). The ChIP results
showed that the recruitment of RAD51 to I-SceI–induced DSB
sites at the 24-h and 48-h time points is much attenuated by NS
knockdown. These ﬁndings, in conjunction with the lack of
RAD51 foci formation in NS-depleted cells, establish the im-
portance of NS in promoting RAD51 recruitment to DSB sites
and refute the possibility that the DNA damage effect of NS
depletion is caused secondarily by increased cellular stress.
Discussion
This study identiﬁes NS as an essential player in protecting
stem/progenitor cells from replication-induced DNA damage in
vivo and demonstrates its ability to bind and promote the re-
cruitment of RAD51 to stalled replication-induced damage foci.
The neNScko mouse model shows that deleting NS in the neural
stem/progenitor cell population increases the frequency of DNA
damage, reduces the number of stem/progenitor cells, and causes
major developmental defects in the embryonic brain. DNA
damage triggered by neNScko becomes most prominent at E12.5.
This window of appearance may be determined collectively by
the activity of nestin promoter and the differentiation and dying
of NS-deleted neural progenitor cells. As a result, the peak of the
NSKO event should parallel or immediately follow the highest
of nestin expression at E10.5 and E12.5 (6). The more DNA
damage events in the E12.5 compared with the E10.5 neuro-
epithelium of neNScko embryos may be caused by the increased
frequency of homozygous deletion of NS (evidenced by the
amount of NS protein reduction) and the increased frequency of
replication stalling events over additional rounds of cell division.
The lack of γ-H2AX signals in the E14.5 or older forebrains may
be due to the rapid loss of proliferative neural precursors. In
support of these in vivo ﬁndings, NS depletion by siNS triggers
massive DNA damage in NSCs and MEF cells and greatly
reduces their ability to self-renew or propagate in culture. The
self-renewing activity of NSCs is indicated by their ability to form
spheres over multiple passages. Given its role in promoting
Fig. 5. NS binds RAD51 and promotes its re-
cruitment to DNA damage foci. (A) Overexpression
of RAD51, but not that of BRCA2 or RPA70, rescues
the γ-H2AX+ cell percentage of NSKO MEF cells.
(B) CoIP of endogenous NS and RAD51 by anti-
RAD51 (left) or anti-NS antibody (right) conﬁrms
that these two proteins interact with each other in
vivo. (C) HU treatment increases the percentages of
γ-H2AX+ in both siScr- and siNS-treated MEF cells.
siNS-treated cells show more DNA damage events
than siScr-treated cells. (D) The HU effect on trig-
gering RAD51+ foci in siNS-treated MEF cells is
signiﬁcantly reduced compared that in siScr-treated
cells. (Scale bar: 50 μm.) (E) DSB-ChIP assays show
that the physical recruitment of RAD51 to I-SceI–
induced DSBs is signiﬁcantly attenuated by NSKD
(siNS) at the 24 and 48-h time points following the
induction of I-SceI expression.
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the RAD51 recruitment during DNA damage repair, loss of
NS is expected to reduce the protection of NSCs against spon-
taneous DNA damage caused by DNA replication, thereby in-
troducing cell cycle arrest and perturbing the formation of tertiary
neurospheres from secondary neurospheres. Notably, restoring
the NS expression can reverse the DNA damage phenotype of
NS-deleted MEF cells, which supports the speciﬁc effect of NS
depletion in causing spontaneous DNA damage in vitro and in
vivo. Finally, we establish the direct role of NS in the response/
repair of DNA damage by showing that NS is physically recruited
to the DSB sites and that the DNA damage effect of NSKO
depends neither on the p53 status nor on the synthesis of rRNAs.
The two major sources of cell-intrinsic DNA damage are ox-
idative stress and replication stalling. We noted that the S-phase
cells are much more susceptible to the NSKO effect than the
non–S-phase cells, a feature also shared by the HU treatment.
This idea that NS deletion leads to replication-dependent DNA
damage is supported by the lack of DNA damage effect of
NSKD on slowly dividing MEF cells and the protective effect of
NS against HU-induced DNA damage in NSCs. Further analyses
identify RAD51 as a direct molecular target of NS with the
ability to rescue the NSKO-induced phenotype. More impor-
tantly, loss of NS perturbs the recruitment efﬁciency of RAD51
to stalled replication-induced damage foci and DSB sites, which
refutes that the DNA damage effect of NS depletion arises
secondarily due to increased cellular stress. Because the DNA
damage phenotype of NSKO cells can be compensated by over-
expressing RAD51 alone, we reason that NS more likely plays
a promoting role than a determining role in the RAD51 re-
cruitment and that the NS-promoted RAD51 recruitment should
be inactive without the preexisting DNA damage event, which,
otherwise, would incur nonspeciﬁc recombination and genomic
instability. This NS function, although modulatory in nature,
becomes indispensable for cells that undergo extended DNA
replication, such that both NSKO and RAD51-KO mice show
the same phenotype of early embryonic lethality (19). In addi-
tion, we noted that this obligatory function of NS does not re-
quire its nucleolar localization and that the damage-induced
foci formation of NS occurs without the apparent translocation
of its protein from the nucleolus to the nucleoplasm, suggesting
that DNA damage may activate the nucleoplasmic NS via a
posttranslational mechanism.
This newly discovered function of NS parallels the one in which
NS protects against DNA damage on the telomere by regulating
telomeric repeat binding factor 1 (TRF1) SUMOylation and the
recruitment of PML-IV (13). Together, these two mechanisms
help protect the genome integrity of stem/progenitor cells through-
out their proliferative lifespan. NS has also been noted to regulate
the p53 pathway via a direct mouse double minute 2 homologue
(MDM2) interaction (9, 10). The MDM2-regulatory mechanism
of NS, however, cannot account for its essential role in cell pro-
liferation and development, as these events do not require the
presence of p53 (11).We have observed that thisMDM2-stabilizing
function of NS is mostly silent under the normal condition and
becomes activated only when the nucleolar organization is disrupted
by stress signals (10). Therefore, our current view is that the DNA/
telomere-protecting function of NS is required for continuously
dividing cells under normal growth conditions and is operated by the
nucleoplasmic pool of NS in a damage-dependent manner, whereas
its MDM2-stabilizing function is only turned on under nucleolar
stress conditions and is operated by the NS protein released from
the disassembled nucleolus.
In conclusion, both in vivo and in vitro studies show that loss
of NS predisposes stem and progenitor cells to spontaneous
DNA damage closely related to the DNA replication event. This
essential function of NS operates independently of p53 or rRNA
synthesis and acts by promoting the DSB recruitment of RAD51.
These discoveries suggest that cells with a robust DNA replica-
tion program may need additional molecules to enhance the core
HR-based repair activity to safeguard their genome integrity.
Materials and Methods
Animal Studies.All animals were housed by the Program for Animal Resources
at the Texas A&M Health Science Center (Houston, TX) and handled in ac-
cordance with the principles of the Guide for the Care and Use of Laboratory
Animals and the procedures approved by the Institutional Animal Care and
Use Committee.
ChIP at DSB Sites. DR-GFP U2OS cells (17) were transfected with the indicated
plasmid or treated with the siRNA duplex. After 24 h, DSBs were introduced
at the I-SceI site on the SceGFP transgene by transfecting with the I-SceI
plasmid, crosslinked with formaldehyde, and subjected to ﬁve rounds of
sonication (8 s) with 1-min interval using the 60 Sonic Dismembrator. Im-
munoprecipitation was performed using the anti–HA- or FLAG-agarose
beads. See SI Materials and Methods for primer sequences.
Other Methods. See SI Materials and Methods for details.
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